CYP17 inhibitors improve the prognosis of metastatic castration-resistant prostate cancer patients: A meta-analysis of published trials Cao Q, Bai P, Shi D, Liao J, Shi H, Xing Y, Chen K, Zhang X -
Steroidal CYP17 Inhibitors for Prostate Cancer Treatment: From Concept to Clinic | IntechOpen
Therapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate Cancer
Assessment of the potential of polyphenols as a CYP17 inhibitor free of adverse corticosteroid elevation. | Semantic Scholar
CYP17 inhibitors for prostate cancer therapy. - Abstract - Europe PMC
CYP17 blockade by abiraterone: further evidence for frequent continued hormone-dependence in castration-resistant prostate cancer | British Journal of Cancer
Steroid/androgen synthesis pathway and the sites of inhibition of... | Download Scientific Diagram